Protection of neurological function in stroke models and neuroprotective properties of lubeluzole

Cerebrovascular Diseases

Volumn 7, Issue SUPPL. 2, 1997, Pages 18-30

  De Ryck, Marc ^a  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Glutamate; Infarct size; Lubeluzole; Motor cortex; Neurological outcome; Neuroprotection; Nitric oxide; Sensorimotor function; Stroke models

Indexed keywords

GLUTAMIC ACID; LUBELUZOLE; NEUROPROTECTIVE AGENT; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; INTRAVENOUS DRUG ADMINISTRATION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; STROKE; TIME;

EID: 0031040927     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108239     Document Type: Conference Paper

References (43)

1. Watson BD, Dietrich WD, Bust, R, Wachtel MS, Ginsberg MD: Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann Neurol 1985;17:497-504.
2. Van Reempts J, Van Deuren B, Van de Ven M, Cornelissen F, Borgers M: Flunarizine reduces cerebral infarct size after photochemically induced thrombosis in spontaneously hypertensive rats. Stroke 1987;18:1113-1119.
3. De Ryck M: Animal models of cerebral stroke: Pharmacological protection of function. Eur Neurol 1990;30(suppl 2):21-27.
4. De Ryck M, Van Reempts J, Borgers M, Wauquier A, Janssen PAJ: Photochemical stroke model: Flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke 1989;20:1383-1390.
5. De Ryck M, Duytschaever H, Pauwels PJ, Janssen PAJ: Ionic channels, cholinergic mechanisms, and recovery of sensorimotor function after neocortical infarcts in rats. Stroke 1990; 21(suppl 3):158-163.
6. De Ryck M, Van Reempts J, Duytschaever H, Van Deuren B, Clincke G: Neocortical localization of tactile/proprioceptive limb-placing reactions in the rat. Brain Res 1992;573:44-60.
7. De Ryck M: Editorial comment. Stroke 1995; 26:23-46.
8. Zilles K, Wree A: Cortex: Areal and laminar structure; in Paxinos G (ed): The Rat Nervous System, ed 2. Sydney, Academic Press, 1995, pp 649-685.
9. Miller MW: The origin of the corticospinal projection neurons in rat. Exp Brain Res 1987;67: 339-351.
10. Wise SP, Murray EA, Coulter JD: Somatotopic organization of corticospinal and corticotrigeminal neurons in the rat. Neuroscience 1979; 4:65-78.
11. Welker C: Microelectrode delineation of fine grain somatotopic organization of SMI cerebral neocortex in albino rat. Brain Res 1971;26: 259-275.
12. Hall RD, Lindholm EP: Organization of motor and somatosensory neocortex in the albino rat. Brain Res 1974;66:23-38.
13. Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD: A model of focal ischemic stroke in the rat: Reproducible extensive cortical infarction. Stroke 1986;17:738-743.
14. Brint S, Jacewicz M, Kiessling M, Tanabe J, Pulsinelli W: Focal brain ischemia in the rat: Methods of reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab 1988;8:474-485.
15. Grabowski M, Sørenson JC, Mattsson B, Zimmer J, Johansson BB: Influence of an enriched environment and cortical grafting on functional outcome in brain infarcts of adult rats. Exp Neurol 1995;133:96-102.
16. Markgraf CG, Green EJ, Hurwitz BE, Morikawa E, Dietrich WD, McCabe PM, Ginsberg MD, Schneiderman N: Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats. Brain Res 1992;575:238-246.
17. Alexis NE, Back T, Zhao W, Dietrich WD, Watson BD, Ginsberg MD: Neurobehavioral consequences of induced spreading depression following photothrombotic middle cerebral artery occlusion. Brain Res 1996;706:273-282.
18. Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD: Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 1996;27:1616-1622.
19. Alexis NE, Dietrich WD, Green EJ, Prado R, Watson BD: Nonocclusive common carotid artery thrombosis in the rat results in reversible sensorimotor and cognitive behavioral deficits. Stroke 1995;26:2338-2346.
20. Dietrich WD, Alonso O, Busto R, Finklestein SP: Posttreatment with intravenous basic fibroblast growth factor reduces histopathological damage folllowing fluid-percussion brain injury in rats. J Neurotrauma 1996;13:309-316.
21. De Ryck M, Keersmaekers R, Clincke G, Janssen M, Van Reel S: Lubeluzole, a novel benzothiazole, protects neurologic function after cerebral thrombotic stroke in rats: An apparent stereospecific effect. Soc Neurosci Abstr 1994;20:185.
22. De Ryck M, Keersmaekers R, Duytschaever H, Claes C, Clincke G, Janssen M, Van Reel G: Lubeluzole protects sensorimotor function and reduces infarct size in a photochemical stroke model in rats. J Pharmacol Exp Ther 1996;279: 748-758.
23. Diener HC, Hacke W, Hennerici M, Rådberg J, Hantson L, De Keyser J: Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Stroke 1996;27:76-81.
24. Aronowski J, Strong MS, Grotta JC: Combined neuroprotection and reperfusion therapy for stroke. Effect of lubeluzole and diaspirin cross-linked hemoglobin in experimental focal ischemia. Stroke 1996;27:1571-1576.
25. Grotta JC: Treatment of experimental focal ischemia in rats with lubeluzole. Cerebrovasc Dis 1997;7(suppl 2):31-34.
26. Haseldonckx M, Van Reempts J, Van de Ven M, Wouters L, Borgers M: Protection with lubeluzole against delayed ischemic brain damage in rats: A quantitative histopathologic study. Stroke, in press.
27. Muramatsu H, Katayama Y, Kamiya T, Mc Kee A, Terashi A: Effect of lubeluzole, a novel neuroprotective agent, on metabolism and PDH activity in ischemia. Cerebrovasc Dis 1996;6(suppl 2):49.
28. Van der Linden A, Verhoye M, De Ryck M: Diffusion-weighted MRI of acute stroke maturation in rats: effects of the novel neuroprotectant lubeluzole. Proc 4th Sci Meet Soc Magn Reson 1996, p 503.
29. Van Reempts J, Ashton D, Willems R, Van de Ven M, Borgers M, Clincke G: Lubeluzole prevents cellular edema in hippocampal slices. 10th Int Brain Edema Symp, San Diego, October 20-23, 1996.
30. Buchkremer-Ratzmann I, Witte OW: Peri-infarct and transhemispheric diaschisis caused by photothrombotic infarction in rat neocortex is reduced by lubeluzole but not MK-801. J Cereb Blood Flow Metab 1995;15(suppl 1): S381.
31. De Ryck M, De Prins E, Nolten C, Marrannes R, Clincke G: Lubeluzole improves ischemic penumbra measured by cortical spreading depressions in rats. Soc Neurosci Abstr 1995;21: 1031.
32. Scheller D, Kolb J, Zacharias E, De Ryck M, Van Reempts J, Clincke G, Tegtmeier F: Extracellular changes of glutamate in the peri-infarct zone. Effect of lubeluzole. J Cereb Blood Flow Metab 1995;15(suppl 1):S379.
33. Osikowska-Evers BA, Wilhelm D, Nebel U, Hennemann P, Scheufler E, Tegtmeier F: The effects of the novel neuroprotective compound lubeluzole on sodium current and veratridine-induced sodium load in rat brain neurons and synaptosomes. J Cereb Blood Flow Metab 1995;15(suppl 1):S380.
34. 2+-overload induced by veratridine in the CA1 region of hippocampal slices. Pharmacol Res 1995;31 (suppl):124.
35. Lesage AS, De Loore KL, Osikowska-Evers B, Peeters L, Leysen JE: Lubeluzole, a novel neuroprotectant, inhibits the glutamate-activated NOS pathway. Soc Neurosci Abstr 1994;20: 185.
36. Montague PR, Gancayco CD, Winn MJ, Marchase RB, Friedlander MJ: Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 1994;263:973-977.
37. Wei K, Matsuyama S, Shuntoh H, Tanaka C: NMDA receptor activation induces glutamate release through nitric oxide synthesis in guinea pig dentate gyrus. Brain Res 1996;728:105-110.
38. Pasantes-Morales H, Chacón E, Sánchez-Olea R, Moran J: Volume regulation in cultured neurons: Pivotal role of taurine; in Huxtable RJ, Michalk D (eds): Taurine in Health and Disease. Adv Exp Med Biol, New York, Plenum Press, 1994, vol 359, pp 317-324.
39. Scheller D, Kolb J, Zacharias E, De Ryck M, Van Reempts J, Clincke G, Tegtmeier F: Extracellular changes of taurine in the peri-infarct zone. Effect of lubeluzole. 10th Int Brain Edema Symp, San Diego, October 20-23, 1996.
40. Van Reempts J, Borgers M: Histopathological Characterization of photochemical damage in nervous tissue. Histol Histopathol 1994;9:185-195.
41. Lesage AS, Peeters L, Leysen JE: Lubeluzole, a novel long-term neuroprotectant, inhibits the glutamate-activated nitric oxide synthase pathway. J Pharmacol Exp Ther 1996;279:759-766.
42. Maiese K, TenBroeke M, Kue I: Neuroprotection of lubeluzole is mediated through the signal transduction pathways of nitric oxide. J Neurochem, in press.
43. Benjamins JA, TenBroeke M, Kue I, Maiese K: Neuroprotection by lubeluzole through the signal transduction pathways of anoxia and nitric oxide. Soc Neurosci Abstr 1996;22:714.